approval · primary record
ADALIMUMAB-BWWD
FDA · BLA · 2026-04-29
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-04-29 |
| Brand | HADLIMA |
| Sponsor | SAMSUNG BIOEPIS CO LTD |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:32.307Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ADALIMUMAB-BWWD:2026-04-29
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Adalimumab-Bwwd · compound